THE ANIMALS-FREE TRACK
A unique track, focused on using innovative technology for removing animals from the food and industrial value chain including cosmetics, pharma, etc. by the introduction of new materials, processes, or other types of technological innovation.
You heard that right! If that’s your mission too - this is your chance at securing a $100k investment!
Focus
The focus of the track covers a wide range of technologies including, but not limited to:
-
Food-Tech
-
Alternative proteins
-
Functional protein
-
Enabling technologies
-
Bio-alternatives solutions
-
Etc.
-
-
Other Industries
-
Bio-Materials
-
Preclinical Testing
-
Vaccine Development (ex: Squalene)
-
Biological drugs
-
Disease models using genetically modified animals
-
Replacing Animal serums and growth factors ex: Fetal Bovine Serum (FBS)
-
Replacing Animal-based materials: Collagen, Heparin, Insulin, etc,
-
Proteomics: Functional proteins for health, nutrition, cosmetics and wellness use
-
Testing methods of ingredients, penetration, toxicity, efficacy during the development process and finished products
-
Etc
-
Scope, Eligibility, and Criteria
-
The track is open to any early-stage ventures established and operating in Israel.
-
At least two founders in the team
-
Founders are NOT LIMITED to be students or graduates of Tel Aviv University
-
Must be "for profit" entities
-
The venture has raised LESS than $200,000 in non-founder equity
-
The venture has a working Prototype / MVP / Alpha / Advanced Demo
-
The finalists must be able to attend the final pitching event.
IMPORTANT
The competition scope DOES NOT cover ventures which aid or facilitate the production of animals. This includes, but is not limited to:
-
Novel crops/proteins for animal feed
-
Probiotic treatments to replace antibiotics for farm animals
-
Tracking and monitoring systems for farm animals
TRACK SPONSOR
Jeremy Coller is Chief Investment Officer at Coller Capital, one of the largest global firms in the secondary private equity market. He is a committed philanthropist and supporter of worldwide teaching and research in entrepreneurship and innovation, including at TAU where he founded the Coller Institute of Venture in 2013. Based on his financial acumen in the private equity market, Financial News named him “Personality of the Decade” in Europe. Jeremy has won numerous accolades from the media – the most recent being in December 2018, when he was recognized by Financial News as one of the 50 most influential people in European private equity.
In 2016, in a milestone event for Tel Aviv University, the Faculty of Management was newly renamed as the Coller School of Management, thanks to a substantial gift from the UK investment wizard and TAU Honorary Doctor Jeremy Coller. The gift aims at taking the School to the next level in management research, and to catapult it to the very top among academic providers of management education in venture, innovation, and entrepreneurship.